{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T11:49:22Z","timestamp":1788954562394,"version":"build-2803163510"},"reference-count":102,"publisher":"Frontiers Media SA","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Front. Med."],"DOI":"10.3389\/fmed.2015.00003","type":"journal-article","created":{"date-parts":[[2015,1,29]],"date-time":"2015-01-29T15:05:17Z","timestamp":1422543917000},"source":"Crossref","is-referenced-by-count":16,"title":["Complement System in Dermatological Diseases \u00e2\u20ac\u201c Fire Under the Skin"],"prefix":"10.3389","volume":"2","author":[{"given":"Janna","family":"Palianus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seppo","family":"Meri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2015,1,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/nature10664","article-title":"Response to self antigen imprints regulatory memory in tissues","volume":"480","author":"Rosenblum","year":"2012","journal-title":"Nature"},{"key":"B2","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.molimm.2005.02.009","article-title":"Human keratinocytes produce the complement inhibitor factor H: synthesis is regulated by interferon-\u00ce\u00b3","volume":"43","author":"Tim\u00c3\u00a1r","year":"2006","journal-title":"Mol Immunol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"2943","DOI":"10.1016\/j.molimm.2007.01.007","article-title":"Human keratinocytes produce the complement inhibitor factor I: synthesis is regulated by interferon-gamma","volume":"44","author":"Tim\u00c3\u00a1r","year":"2007","journal-title":"Mol Immunol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/jid.2013.346","article-title":"Complement factor H: a biomarker for progression of cutaneous squamous cell carcinoma","volume":"134","author":"Riihil\u00c3\u00a4","year":"2014","journal-title":"J Invest Dermatol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.1016\/j.molimm.2006.12.014","article-title":"Expression of terminal complement components by human keratinocytes","volume":"44","author":"Tim\u00c3\u00a1r","year":"2007","journal-title":"Mol Immunol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1111\/1523-1747.ep12513524","article-title":"A-431 cells and human keratinocytes synthesize and secrete the third component of complement","volume":"95","author":"Basset-Seguin","year":"1990","journal-title":"J Invest Dermatol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1111\/1523-1747.ep12499812","article-title":"Human keratinocytes and A-431 cells synthesize and secrete factor B, the major zymogen protease of the alternative complement pathway","volume":"98","author":"Yancey","year":"1992","journal-title":"J Invest Dermatol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1172\/JCI116080","article-title":"Expression and localization of proteins of the complement system in human skin","volume":"90","author":"Dovezenski","year":"1992","journal-title":"J Clin Invest"},{"key":"B9","first-page":"327","article-title":"Complement as a part of the skin immune system","volume-title":"Skin Immune System","author":"Asghar","year":"2005"},{"key":"B10","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/S0002-9440(10)65295-9","article-title":"C5a receptor and interleukin-6 are expressed in tissue macrophages and stimulated keratinocytes but not in pulmonary and intestinal epithelial cells","volume":"154","author":"Fayyazi","year":"1999","journal-title":"Am J Pathol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1002\/(SICI)1521-4141(199901)29:01100::AID-IMMU1003.3.CO;2-I","article-title":"Transforming growth factor-beta isoforms regulate the surface expression of membrane cofactor protein (CD46) and CD59 on human keratinocytes","volume":"29","author":"Pasch","year":"1999","journal-title":"Eur J Immunol"},{"key":"B12","doi-asserted-by":"crossref","first-page":"4675","DOI":"10.4049\/jimmunol.144.12.4675","article-title":"Enhanced synthesis of factor B induced by tumor necrosis factor in human skin fibroblasts is decreased by IL-4","volume":"12","author":"Katz","year":"1990","journal-title":"J Immunol"},{"key":"B13","doi-asserted-by":"crossref","first-page":"559","DOI":"10.4049\/jimmunol.141.2.559","article-title":"Synthesis and regulation of complement protein factor H in human skin fibroblasts","volume":"2","author":"Katz","year":"1988","journal-title":"J Immunol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/263145a0","article-title":"C1q production and secretion by fibroblasts","volume":"263","author":"Al-Adnani","year":"1976","journal-title":"Nature"},{"key":"B15","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1111\/j.1365-3083.1990.tb03196.x","article-title":"Synthesis of C3, C5, C6, C7, C8 and C9 by human fibroblasts","volume":"32","author":"Garred","year":"1990","journal-title":"Scand J Immunol"},{"key":"B16","first-page":"196","article-title":"Regulation of the synthesis of C1 subcomponents and C1-inhibitor","volume":"93","author":"Gulati","year":"1993","journal-title":"Behring Inst Mitt"},{"key":"B17","first-page":"32","article-title":"The biosynthesis of C1q, the collagen-like and Fc-recognizing molecule of the complement system","volume":"84","author":"Loos","year":"1989","journal-title":"Behring Inst Mitt"},{"key":"B18","doi-asserted-by":"crossref","first-page":"4624","DOI":"10.4049\/jimmunol.152.9.4624","article-title":"Complement component C7. Assessment of in vivo synthesis after liver transplantation reveals that hepatocytes do not synthesize the majority of human C7","volume":"152","author":"W\u00c3\u00bcrzner","year":"1994","journal-title":"J Immunol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1111\/1523-1747.ep12476743","article-title":"Decay-accelerating factor is associated with elastic fibers","volume":"91","author":"Werth","year":"1988","journal-title":"J Invest Dermatol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/1523-1747.ep12514737","article-title":"Characterization of decay-accelerating factor (DAF) in human skin","volume":"96","author":"Sayama","year":"1991","journal-title":"J Invest Dermatol"},{"key":"B21","doi-asserted-by":"crossref","first-page":"461","DOI":"10.2340\/0001555566461467","article-title":"Localization of vitronectin (S-protein of complement) in normal human skin","volume":"66","author":"Dahlb\u00c3\u00a4ck","year":"1986","journal-title":"Acta Derm Venereol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1007\/BF00638232","article-title":"The role of complement-derived mediators in inflammatory skin diseases","volume":"284","author":"Tagami","year":"1992","journal-title":"Arch Dermatol Res"},{"key":"B23","doi-asserted-by":"publisher","first-page":"33293","DOI":"10.1074\/jbc.R100016200","article-title":"The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. Evolution, mechanism of inhibition, novel functions, and a revised nomenclature","volume":"276","author":"Silverman","year":"2001","journal-title":"J Biol Chem"},{"key":"B24","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.molmed.2008.12.001","article-title":"C1-inhibitor deficiency and angioedema: molecular mechanisms and clinical progress","volume":"15","author":"Cugno","year":"2009","journal-title":"Trends Mol Med"},{"key":"B25","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/S0140-6736(00)02483-1","article-title":"Hereditary angioedema with normal C1-inhibitor activity in women","volume":"356","author":"Bork","year":"2000","journal-title":"Lancet"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1086\/509899","article-title":"Increased activity of coagulation factor XII (Hageman factor) causes hereditary angioedema type III","volume":"79","author":"Cichon","year":"2006","journal-title":"Am J Hum Genet"},{"key":"B27","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2500\/aap.2009.30.3188","article-title":"The spectrum of chronic angioedema","volume":"30","author":"Banerji","year":"2009","journal-title":"Allergy Asthma Proc"},{"key":"B28","doi-asserted-by":"publisher","first-page":"S262","DOI":"10.1016\/j.jaci.2009.10.063","article-title":"Complement disorders and hereditary angioedema","volume":"125","author":"Frank","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1172\/JCI114084","article-title":"Acquired C1-inhibitor (C1-INH) deficiency type II. Replacement therapy with C1-INH and analysis of patients\u00e2\u20ac\u2122 C1-INH and anti-C1-INH autoantibodies","volume":"83","author":"Alsenz","year":"1989","journal-title":"J Clin Invest"},{"key":"B30","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.iac.2006.08.002","article-title":"Acquired deficiency of the inhibitor of the first complement component: presentation, diagnosis, course, and conventional management","volume":"26","author":"Zingale","year":"2006","journal-title":"Immunol Allergy Clin North Am"},{"key":"B31","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1159\/000075689","article-title":"The intricate role of complement component C4 in human systemic lupus erythematosus","volume":"7","author":"Yang","year":"2004","journal-title":"Curr Dir Autoimmun"},{"key":"B32","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S0162-3109(99)00018-1","article-title":"Systemic lupus erythematosus and complement deficiency: clues to a novel role for the classical complement pathway in the maintenance of immune tolerance","volume":"42","author":"Navratil","year":"1999","journal-title":"Immunopharmacology"},{"key":"B33","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/ng0598-56","article-title":"Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies","volume":"19","author":"Botto","year":"1998","journal-title":"Nat Genet"},{"key":"B34","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1146\/annurev.immunol.22.012703.104549","article-title":"The role of complement in the development of systemic lupus erythematosus","volume":"22","author":"Manderson","year":"2004","journal-title":"Annu Rev Immunol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1084\/jem.181.4.1557","article-title":"Novel packages of viral and self-antigens are generated during apoptosis","volume":"181","author":"Rosen","year":"1995","journal-title":"J Exp Med"},{"key":"B36","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1002\/art.1780310401","article-title":"Evidence for the presence of autoantibodies to the collagen-like portion of C1q in systemic lupus erythematosus","volume":"31","author":"Antes","year":"1988","journal-title":"Arthritis Rheum"},{"key":"B37","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1016\/j.molimm.2006.09.009","article-title":"Detection of autoantibodies against the globular domain of human C1q in the sera of systemic lupus erythematosus patients","volume":"44","author":"Tsacheva","year":"2007","journal-title":"Mol Immunol"},{"key":"B38","doi-asserted-by":"crossref","first-page":"265","DOI":"10.4049\/jimmunol.135.1.265","article-title":"Low molecular weight C1q in systemic lupus erythematosus","volume":"135","author":"Hoekzema","year":"1985","journal-title":"J Immunol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1177\/0961203309357059","article-title":"C1-inhibitor autoantibodies in SLE","volume":"19","author":"M\u00c3\u00a9sz\u00c3\u00a1ros","year":"2010","journal-title":"Lupus"},{"key":"B40","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1046\/j.1365-2249.2003.02274.x","article-title":"Autoantibodies against mannose-binding lectin in systemic lupus erythematosus","volume":"134","author":"Seelen","year":"2003","journal-title":"Clin Exp Immunol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"R557","DOI":"10.1186\/ar1224","article-title":"Analysis of HLA DR, HLA DQ, C4A, Fcgamma RIIa, Fcgamma RIIIA, MBL and IL-1Ra allelic variants in Caucasian systemic lupus erythematosus patients suggests an effect of combined Fcgamma RIIa R\/R and IL-1Ra 2\/2 genotypes on disease susceptibility","volume":"6","author":"J\u00c3\u00b6nsen","year":"2004","journal-title":"Arthritis Res Ther"},{"key":"B42","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1111\/j.1365-2249.1993.tb03392.x","article-title":"Local and systemic activation of the whole complement cascade in human leukocytoclastic cutaneous vasculitis; C3dg and terminal complement complex as sensitive markers","volume":"92","author":"Dauchel","year":"1993","journal-title":"Clin Exp Immunol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/BF00372620","article-title":"Membrane attack complex of complement in Henoch-Sch\u00c3\u00b6nlein purpura skin and nephritis","volume":"282","author":"Kawana","year":"1990","journal-title":"Arch Dermatol Res"},{"key":"B44","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1046\/j.1365-2133.1996.117852.x","article-title":"The use of antibody to C5b-9 in the subclassification of lupus erythematosus","volume":"134","author":"Magro","year":"1996","journal-title":"Br J Dermatol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.imlet.2011.06.006","article-title":"Cross-talk between the complement and the kinin system in vascular permeability","volume":"140","author":"Bossi","year":"2011","journal-title":"Immunol Lett"},{"issue":"Suppl 127","key":"B46","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/j.1600-0463.2009.02477.x","article-title":"The contact\/kinin and complement systems in vasculitis","volume":"117","author":"Karpman","year":"2009","journal-title":"APMIS"},{"key":"B47","doi-asserted-by":"publisher","first-page":"52","DOI":"10.2353\/ajpath.2007.060573","article-title":"Alternative complement pathway in the pathogenesis of disease mediated by anti-neutrophil cytoplasmic autoantibodies","volume":"170","author":"Xiao","year":"2007","journal-title":"Am J Pathol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1007\/s11926-009-0060-y","article-title":"Hypocomplementemic urticarial vasculitis syndrome","volume":"11","author":"Jara","year":"2009","journal-title":"Curr Rheumatol Rep"},{"key":"B49","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.autrev.2008.06.006","article-title":"Anti-C1q antibodies","volume":"8","author":"Kallenberg","year":"2008","journal-title":"Autoimmun Rev"},{"key":"B50","doi-asserted-by":"publisher","first-page":"184","DOI":"10.3346\/jkms.2009.24.1.184","article-title":"Hypocomplementemic urticarial vasculitis in systemic lupus erythematosus","volume":"24","author":"Her","year":"2009","journal-title":"J Korean Med Sci"},{"key":"B51","first-page":"215","article-title":"Pemphigus vulgaris: recent advances in our understanding of its pathogenesis","volume":"56","author":"Femiano","year":"2007","journal-title":"Minerva Stomatol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1111\/j.1601-0825.2011.01899.x","article-title":"Urban legends: pemphigus vulgaris","volume":"18","author":"Cirillo","year":"2012","journal-title":"Oral Dis"},{"key":"B53","doi-asserted-by":"publisher","first-page":"72s","DOI":"10.1111\/1523-1747.ep12275497","article-title":"Immunopathologic mechanisms in pemphigus and bullous pemphigoid","volume":"85","author":"Jordon","year":"1985","journal-title":"J Invest Dermatol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1111\/1523-1747.ep12709624","article-title":"Deposition of the membrane attack complex of complement in pemphigus vulgaris and pemphigus foliaceus skin","volume":"92","author":"Kawana","year":"1989","journal-title":"J Invest Dermatol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00403-007-0734-0","article-title":"The relevance of the IgG subclass of autoantibodies for blister induction in autoimmune bullous skin diseases","volume":"299","author":"Sitaru","year":"2007","journal-title":"Arch Dermatol Res"},{"key":"B56","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1111\/j.1365-2230.2005.01937.x","article-title":"Collagen XVII\/BP180: a collagenous transmembrane protein and component of the dermoepidermal anchoring complex","volume":"30","author":"Powell","year":"2005","journal-title":"Clin Exp Dermatol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1111\/j.1346-8138.2009.00792.x","article-title":"What\u00e2\u20ac\u2122s new in bullous pemphigoid","volume":"37","author":"Ujiie","year":"2010","journal-title":"J Dermatol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"128","DOI":"10.2302\/kjm.52.128","article-title":"Immunopathology of bullous pemphigoid, an autoimmune and inflammatory skin blistering disease","volume":"52","author":"Liu","year":"2003","journal-title":"Keio J Med"},{"key":"B59","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s12026-008-8028-y","article-title":"Complement and cutaneous autoimmune blistering diseases","volume":"41","author":"Lessey","year":"2008","journal-title":"Immunol Res"},{"key":"B60","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1001\/archderm.143.2.215","article-title":"Childhood bullous pemphigoid: clinical and immunological findings in a series of 4 cases","volume":"143","author":"Martinez-De Pablo","year":"2007","journal-title":"Arch Dermatol"},{"key":"B61","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1468-3083.2004.01132.x","article-title":"Immunoglobulin, complement and epidermal transglutaminase deposition in the cutaneous vessels in dermatitis herpetiformis","volume":"19","author":"Preisz","year":"2005","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/BF02786513","article-title":"Partial lipodystrophy, mesangiocapillary glomerulonephritis, and complement dysregulation","volume":"18","author":"Levy","year":"1998","journal-title":"Immunol Res"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1681\/ASN.2005010078","article-title":"Membranoproliferative glomerulonephritis type II (dense deposit disease): an update","volume":"16","author":"Appel","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"B64","first-page":"298","article-title":"Lupus, C3 nephritic factor and partial lipodystrophy","volume":"88","author":"Cronin","year":"1995","journal-title":"Q J Med"},{"key":"B65","first-page":"82","article-title":"C3 nephritic factor and C4 nephritic factor in the serum of two patients with hypocomplementaemic membranoproliferative glomerulonephritis","volume":"76","author":"Tanuma","year":"1989","journal-title":"Clin Exp Immunol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1210\/jc.2008-1703","article-title":"Complement abnormalitis in acquired lipodystrophy revisited","volume":"94","author":"Savage","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"B67","volume-title":"Complement. Clinical Aspects and Relevance to Disease","author":"Morgan","year":"1990"},{"key":"B68","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.humimm.2009.10.014","article-title":"HLA-DRB1*01 allele and low plasma immunoglobulin G1 concentration may predispose to herpes-associated recurrent lymphocytic meningitis","volume":"71","author":"Kallio-Laine","year":"2010","journal-title":"Hum Immunol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.molimm.2005.02.017","article-title":"Association between combined properdin and mannose-binding lectin deficiency and infection with Neisseria meningitidis","volume":"43","author":"Bathum","year":"2006","journal-title":"Mol Immunol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.tim.2007.03.005","article-title":"Interactions between Neisseria meningitidis and the complement system","volume":"15","author":"Schneider","year":"2007","journal-title":"Trends Microbiol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.ijmm.2007.05.002","article-title":"Epidemiological aspects and molecular characterization of Borrelia burgdorferi s.l. from southern Germany with special respect to the new species Borrelia spielmanii sp. nov","volume":"298","author":"Fingerle","year":"2008","journal-title":"Int J Med Microbiol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.resmic.2008.05.005","article-title":"Characterization of Borrelia burgdorferi sensu lato isolates by pulsed-field gel electrophoresis after M1uI restriction of genomic DNA","volume":"159","author":"Ruzic-Sabljic","year":"2008","journal-title":"Res Microbiol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/S0140-6736(11)60103-7","article-title":"Lyme borreliosis","volume":"379","author":"Stanek","year":"2012","journal-title":"Lancet"},{"key":"B74","doi-asserted-by":"publisher","first-page":"3685","DOI":"10.1128\/IAI.69.6.3685-3691.2001","article-title":"Complement evasion by Borrelia burgdorferi: serum-resistant strains promote C3b inactivation","volume":"69","author":"Alitalo","year":"2001","journal-title":"Infect Immun"},{"key":"B75","doi-asserted-by":"publisher","first-page":"8427","DOI":"10.1074\/jbc.M007994200","article-title":"The complement regulator factor H binds to the surface protein OspE of Borrelia burgdorferi","volume":"276","author":"Hellwage","year":"2001","journal-title":"J Biol Chem"},{"key":"B76","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/S1567-5769(00)00041-2","article-title":"Mechanism of complement resistance of pathogenic Borrelia burgdorferi isolates","volume":"1","author":"Kraiczy","year":"2001","journal-title":"Int Immunopharmacol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1016\/j.molimm.2009.11.028","article-title":"Binding of the complement inhibitor C4b-binding protein to Lyme disease Borreliae","volume":"47","author":"Pietik\u00c3\u00a4inen","year":"2010","journal-title":"Mol Immunol"},{"key":"B78","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.micpath.2010.06.006","article-title":"Expression and sequence diversity of the complement regulating outer surface protein E in Borrelia afzelii vs. B. garinii in patients with erythema migrans or neuroborreliosis","volume":"49","author":"Panelius","year":"2010","journal-title":"Microb Pathog"},{"key":"B79","doi-asserted-by":"publisher","first-page":"3299","DOI":"10.4049\/jimmunol.175.5.3299","article-title":"Complement regulator acquiring surface protein 1 (CRASP-1) imparts resistance to human serum in B. burgdorferi","volume":"175","author":"Brooks","year":"2005","journal-title":"J Immunol"},{"key":"B80","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.1128\/IAI.00318-09","article-title":"CspA-mediated binding of human factor H inhibits complement deposition and confers serum resistance in Borrelia burgdorferi","volume":"77","author":"Kenedy","year":"2009","journal-title":"Infect Immun"},{"key":"B81","doi-asserted-by":"publisher","first-page":"3847","DOI":"10.4049\/jimmunol.169.7.3847","article-title":"Complement inhibitor factor H binding to Lyme disease spirochetes is mediated by inducible expression of multiple plasmid-encoded outer surface protein E paralogs","volume":"169","author":"Alitalo","year":"2002","journal-title":"J Immunol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1128\/IAI.70.2.491-497.2002","article-title":"Differential binding of host complement inhibitor factor H by Borrelia burgdorferi Erp surface proteins: a possible mechanism underlying the expansive host range of Lyme disease spirochetes","volume":"70","author":"Stevenson","year":"2002","journal-title":"Infect Immun"},{"key":"B83","doi-asserted-by":"publisher","first-page":"6195","DOI":"10.4049\/jimmunol.172.10.6195","article-title":"Lysine-dependent multipoint binding of the Borrelia burgdorferi virulence factor outer surface protein E to the C terminus of factor H","volume":"172","author":"Alitalo","year":"2004","journal-title":"J Immunol"},{"key":"B84","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1128\/IAI.63.1.149-153.1995","article-title":"Location of the complement factor H binding site on streptococcal M6 protein","volume":"63","author":"Fischetti","year":"1995","journal-title":"Infect Immun"},{"key":"B85","doi-asserted-by":"crossref","first-page":"375","DOI":"10.4049\/jimmunol.154.1.375","article-title":"Ig-binding surface proteins of Streptococcus pyogenes also bind human C4b-binding protein (C4BP), a regulatory component of the complement system","volume":"154","author":"Thern","year":"1995","journal-title":"J Immunol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"8144","DOI":"10.1073\/pnas.82.23.8144","article-title":"Mechanism of action of the group A streptococcal C5a inactivator","volume":"82","author":"Wexler","year":"1985","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B87","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S0161-5890(03)00108-1","article-title":"Complement resistance mechanisms of streptococci","volume":"40","author":"Jarva","year":"2003","journal-title":"Mol Immunol"},{"key":"B88","doi-asserted-by":"publisher","first-page":"426","DOI":"10.4049\/jimmunol.1102545","article-title":"Acquisition of complement factor H is important for pathogenesis of Streptococcus pyogenes infections: evidence from bacterial in vitro and human genetic association","volume":"188","author":"Haapasalo","year":"2012","journal-title":"J Immunol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1056\/NEJM199808203390806","article-title":"Staphylococcus aureus infections","volume":"339","author":"Lewy","year":"1998","journal-title":"N Engl J Med"},{"key":"B90","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.4049\/jimmunol.1300638","article-title":"Staphylococcal Ecb protein and host complement regulator factor H enhance functions of each other in bacterial immune evasion","volume":"191","author":"Amdahl","year":"2013","journal-title":"J Immunol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"e1000250","DOI":"10.1371\/journal.ppat.1000250","article-title":"The Staphylococcus aureus protein Sbi acts as a complement inhibitor and forms a tripartite complex with host complement factor H and C3b","volume":"4","author":"Haupt","year":"2008","journal-title":"PLoS Pathog"},{"key":"B92","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1160\/TH04-08-0501","article-title":"Extracellular fibrinogen binding protein, Efb, from Staphylococcus aureus as an antiplatelet agent in vivo","volume":"93","author":"Shannon","year":"2005","journal-title":"Thromb Haemost"},{"key":"B93","doi-asserted-by":"publisher","first-page":"50710","DOI":"10.1074\/jbc.M408570200","article-title":"Identification and characterization of the C3 binding domain of the Staphylococcus aureus extracellular fibrinogen-binding protein (Efb)","volume":"279","author":"Lee","year":"2004","journal-title":"J Biol Chem"},{"key":"B94","doi-asserted-by":"publisher","first-page":"17621","DOI":"10.1073\/pnas.1003750107","article-title":"Allosteric inhibition of complement function by a staphylococcal immune evasion protein","volume":"107","author":"Chen","year":"2010","journal-title":"Proc. Natl Acad Sci U S A"},{"key":"B95","doi-asserted-by":"publisher","first-page":"e1003816","DOI":"10.1371\/journal.ppat.1003816","article-title":"Phagocytosis escape by a Staphylococcus aureus protein that connects complement and coagulation proteins at the bacterial surface","volume":"9","author":"Ko","year":"2013","journal-title":"PLoS Pathog"},{"key":"B96","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1111\/j.1398-9995.2007.01577.x","article-title":"Treatment of skin swellings with C1-inhibitor concentrate in patients with hereditary angio-oedema","volume":"63","author":"Bork","year":"2008","journal-title":"Allergy"},{"key":"B97","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.jaci.2009.07.017","article-title":"Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks","volume":"124","author":"Craig","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"B98","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s002770050321","article-title":"C1 esterase inhibitor concentrate for capillary leakage syndrome following bone marrow transplantation","volume":"75","author":"Nurnberger","year":"1997","journal-title":"Ann Hematol"},{"key":"B99","doi-asserted-by":"publisher","first-page":"494","DOI":"10.3109\/00365548.2012.755268","article-title":"A severe case of Puumala hantavirus infection successfully treated with bradykinin receptor antagonist icatibant","volume":"45","author":"Antonen","year":"2013","journal-title":"Scand J Infect Dis"},{"key":"B100","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/nrd2369","article-title":"Fresh from the pipeline: eculizumab","volume":"6","author":"Parker","year":"2007","journal-title":"Nat Rev Drug Discov"},{"key":"B101","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1111\/j.1365-2141.2012.09084.x","article-title":"Ecilizumab in the treatment of refractory idiopathic thrombotic thrombocytopenic purpura","volume":"157","author":"Chapin","year":"2012","journal-title":"Br J Haematol"},{"key":"B102","doi-asserted-by":"publisher","first-page":"I113","DOI":"10.1016\/j.vaccine.2008.11.058","article-title":"Microbial complement inhibitors as vaccines","volume":"26S","author":"Meri","year":"2008","journal-title":"Vaccine"}],"container-title":["Frontiers in Medicine"],"original-title":[],"deposited":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T22:12:56Z","timestamp":1717711976000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fmed.2015.00003\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,29]]},"references-count":102,"URL":"https:\/\/doi.org\/10.3389\/fmed.2015.00003","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,29]]}}}